Emergent BioSolutions
EBS
#8134
Rank
NZ$0.64 B
Marketcap
NZ$12.58
Share price
3.67%
Change (1 day)
-20.62%
Change (1 year)

Earnings for Emergent BioSolutions (EBS)

Earnings in 2026 (TTM): -NZ$0.17 Billion

According to Emergent BioSolutions 's latest financial reports the company's current earnings are NZ$0.74 Billion. In 2025 the company made an earning of NZ$0.25 Billion, an increase over its 2024 earnings that were of -NZ$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Emergent BioSolutions from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.17 Billion-166.97%
2025 NZ$0.25 B-297.64%
2024 -NZ$0.13 Billion-88.82%
2023 -NZ$1.15 Billion242.73%
2022 -NZ$0.34 Billion-153.8%
2021 NZ$0.62 B-20.43%
2020 NZ$0.78 B278.02%
2019 NZ$0.20 B27.11%
2018 NZ$0.16 B-27.12%
2017 NZ$0.22 B17.21%
2016 NZ$0.19 B0.45%
2015 NZ$0.18 B73.51%
2014 NZ$0.10 B41.36%
2013 NZ$77.27 M35.2%
2012 NZ$57.15 M0.4%
2011 NZ$56.92 M-56.46%
2010 NZ$0.13 B76.73%
2009 NZ$73.98 M32.94%
2008 NZ$55.65 M-5.62%
2007 NZ$58.96 M
2005 NZ$85.37 M269.89%
2004 NZ$23.08 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
NZ$12.30 B-7,362.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.70 B-8,186.23%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$14.05 B-8,396.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Soligenix
SNGX
-NZ$20.86 Million-87.69%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
-NZ$19.85 Million-88.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-NZ$0.59 Billion 242.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.85 B-1,787.70%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel